Literature DB >> 18612042

Effects of oral carbohydrate on autonomic nervous system counterregulatory responses during hyperinsulinemic hypoglycemia and euglycemia.

Andrew C Ertl1, Stephnie Mann, Antoinette Richardson, Vanessa J Briscoe, Hannah B Blair, Donna B Tate, Stephen N Davis.   

Abstract

The effects of oral carbohydrate on modulating counterregulatory responses in humans remain undecided. This study's specific aim was to determine the effects of oral carbohydrate on autonomic nervous system (ANS) and neuroendocrine responses during hyperinsulinemic hypoglycemia and euglycemia. Nineteen healthy volunteers were studied during paired, single blind experiments. Nine subjects underwent two-step glucose clamps consisting of 60 min of euglycemia (5.0 mmol/l) followed by either 15 g of oral carbohydrate (cal) as orange juice or a noncaloric control (nocal) and subsequent 90 min of clamped hypoglycemia (2.9 mmol/l). Ten other subjects underwent two randomized 150-min hyperinsulinemic-euglycemic clamps with cal or nocal control administered at 60 min. Oral carbohydrate initially blunted (P < 0.05) epinephrine, norepinephrine, cortisol, glucagon, pancreatic polypeptide, muscle sympathetic nerve activity (MSNA), symptom, and systolic blood pressure responses during hypoglycemia. However, by the end of 90 min of hypoglycemia, plasma epinephrine and norepinephrine responses had rebounded and were increased (P < 0.05) compared with control. MSNA and cortisol levels remained suppressed during hypoglycemia (P < 0.05) after cal, whereas pancreatic polypeptide, glucagon, symptom, and blood pressure responses increased similar to control following initial suppression. Oral carbohydrate had no effects on neuroendocrine or ANS responses during hyperinsulinemic euglycemia. These results demonstrate that oral carbohydrate can have differential effects on the time course of ANS and neuroendocrine responses during hypoglycemia. We conclude that gastro-splanchnic-portal sensing of an amount of carbohydrate recommended for use in clinical practice for correction of hypoglycemia can have widespread and significant effects on central nervous system mediated counterregulatory responses in healthy humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612042      PMCID: PMC2536735          DOI: 10.1152/ajpendo.90470.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  37 in total

1.  The increase in sympathetic nerve activity after glucose ingestion is reduced in type I diabetes.

Authors:  J Fagius; C Berne
Journal:  Clin Sci (Lond)       Date:  2000-05       Impact factor: 6.124

2.  Hypoglycemic detection does not occur in the hepatic artery or liver: findings consistent with a portal vein glucosensor locus.

Authors:  A L Hevener; R N Bergman; C M Donovan
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

3.  Oral glucose augments the counterregulatory hormone response during insulin-induced hypoglycemia in humans.

Authors:  R A Heptulla; W V Tamborlane; T Y Ma; F Rife; R S Sherwin
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

4.  Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.

Authors:  Michael A Nauck; Markus M Heimesaat; Kai Behle; Jens J Holst; Markus S Nauck; Robert Ritzel; Michael Hüfner; Wolff H Schmiegel
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

5.  Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia.

Authors:  A L Hevener; R N Bergman; C M Donovan
Journal:  Diabetes       Date:  2000-01       Impact factor: 9.461

6.  Differential gender responses to hypoglycemia are due to alterations in CNS drive and not glycemic thresholds.

Authors:  S N Davis; C Shavers; F Costa
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-11       Impact factor: 4.310

7.  The role of hepatic portal glucose sensing in modulating responses to hypoglycaemia in man.

Authors:  D Smith; A Pernet; H Reid; E Bingham; J M Rosenthal; I A Macdonald; A M Umpleby; S A Amiel
Journal:  Diabetologia       Date:  2002-08-16       Impact factor: 10.122

8.  Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans.

Authors:  S N Davis; S Mann; P Galassetti; R A Neill; D Tate; A C Ertl; F Costa
Journal:  Diabetes       Date:  2000-11       Impact factor: 9.461

9.  Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia.

Authors:  Farhad Zangeneh; Rita Basu; Pankaj Shah; Puneet Arora; Michael Camilleri; Robert A Rizza
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-08       Impact factor: 4.310

10.  Impaired glucagon response to sympathetic nerve stimulation in the BB diabetic rat: effect of early sympathetic islet neuropathy.

Authors:  Thomas O Mundinger; Qi Mei; Dianne P Figlewicz; Ake Lernmark; Gerald J Taborsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-07-22       Impact factor: 4.310

View more
  5 in total

1.  Basal alpha-cell up-regulation in obese insulin-resistant adolescents.

Authors:  Ram Weiss; Ebe D'Adamo; Nicola Santoro; Karen Hershkop; Sonia Caprio
Journal:  J Clin Endocrinol Metab       Date:  2010-09-15       Impact factor: 5.958

2.  2. Hypoglycemia Detection.

Authors:  Vanessa H Routh; Casey M Donovan; Sue Ritter
Journal:  Transl Endocrinol Metab       Date:  2012-12

3.  Gastric bypass alters both glucose-dependent and glucose-independent regulation of islet hormone secretion.

Authors:  Marzieh Salehi; Stephen C Woods; David A D'Alessio
Journal:  Obesity (Silver Spring)       Date:  2015-08-28       Impact factor: 5.002

4.  Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans.

Authors:  Paolo Rossetti; Francesca Porcellati; Paola Lucidi; Natalia Busciantella Ricci; Paola Candeloro; Patrizia Cioli; Fausto Santeusanio; Geremia B Bolli; Carmine G Fanelli
Journal:  Diabetes       Date:  2008-10-13       Impact factor: 9.461

5.  Hypoglycemic detection at the portal vein: absent in humans or yet to be elucidated?

Authors:  Casey M Donovan; Maryann Bohland
Journal:  Diabetes       Date:  2009-01       Impact factor: 9.461

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.